InnoCure Therapeutics is a privately held
biopharmaceutical company dedicated to the discovery
and development of novel drugs based on next-generation
protein degradation mechanisms applicable to
'undruggable' targets and rare diseases.
We endeavor to develop novel drug candidates to address
dramatically unmet medical needs and to advance our
product candidates into the global market for
out-licensing or in-licensing opportunities.